Myelitis, Transverse - 7 Studies Found

Recruiting : A Double Blind Trial To Evaluate The Safety And Efficacy Of Eculizumab In Relapsing NMO Patients (PREVENT Study)
:
  • Neuromyelitis Optica
  • Neuromyelitis Optica Spectrum Disorder

: 2013-06-20
: Drug: Eculizumab Induction Phase: 900 mg IV weekly X 4 Mai
Active, not recruiting : A Longitudinal Study of ACTEMRA® (Tocilizumab) as Monotherapy in Highly Active NMOSD
:
  • Neuromyelitis Optica Spectrum Disorders
  • Neuromyelitis Optica
  • Drug: Azathioprine Patients ar
Completed : Neuromyelitis Optica (NMO) & Cetirizine
: Neuromyelitis Optica
: 2016-08-09
: Drug: cetirizine Other Name: Zyrtec
Recruiting : Efficacy and Safety Study as Monotherapy of SA237 to Treat NMO and NMOSD
: Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)
: 2014-02-25
:
  • Drug: SA237
  • Drug: Placebo
Recruiting : Efficacy and Safety Study as Add-on Therapy of SA237 to Treat NMO and NMOSD
:
  • Neuromyelitis Optica (NMO)
  • NMO Spectrum Disorder (NMOSD)

: 2014-01-06
:
  • Drug: SA237
  • Drug: Placebo
Completed : C1-esterase Inhibitor (Cinryze) for Acute Treatment of Neuromyelitis Optica Exacerbation
: Neuromyelitis Optica
: 2012-12-29
: Drug: C1-esterase inhibitor (Cinryze) Other Name: Cinryze